News

Under the terms of the agreement, S*BIO is eligible to receive up to $550 million in combined equity purchase, option and license fees, and development and sales milestone

Seppro depletion products enable scientists to measure more precisely the expression of protein biomarkers from a range of mammalian and plant biological samples. This acquisition covers current inventory,

Cerec AC is built on Sirona’s proprietary Cerec Bluecam technology and its automatic image capture system operates in such a way that entire quadrants can be scanned in

As a prerequisite for approval of Cimzia, the FDA has requested a new safety update with all clinical data including new data generated since the filing of the

Most recently, Popovits served as as senior vice president, marketing and sales. She holds a B.A. in business from Michigan State University. Cole comes to Genomic in 2004

The PD2i Analyzer uses Vicor’s patented, proprietary point correlation dimension algorithm (PD2i), a deterministic, non-linear measure that analyzes ECG data to risk stratify target populations as to future

The final value of the MDS Pharma Services goodwill write-down, previously estimated to be in the range of $270 million to $370 million, is $320 million. Including the

The National Cancer Centre of Singapore (NCCS) said that it selected nimotuzumab because of its reported preferential safety profile compared with other epidermal growth factor receptor (EGFR)-targeting cancer

The company will conduct a Phase II trial in approximately 128 patients with non-small cell lung cancer (NSCLC) and a Phase II trial in approximately 88 patients with